Pdt Partners, LLC Assembly Biosciences, Inc. Transaction History

Pdt Partners, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.8 - $4.56 $1.04 Million - $1.25 Million	-274,476 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.33 - $6.63 $1.05 Million - $1.6 Million	241,576 Added 734.27%	274,476 $1.26 Million
Q4 2020 Feb 16, 2021	BUY	$4.87 - $17.29 $108,985 - $386,932	22,379 Added 212.71%	32,900 $199,000
Q3 2020 Nov 16, 2020	SELL	$15.08 - $27.04 $220,228 - $394,892	-14,604 Reduced 58.13%	10,521 $173,000
Q2 2020 Aug 14, 2020	SELL	$14.57 - $23.96 $387,984 - $638,030	-26,629 Reduced 51.45%	25,125 $586,000

Q1 2020 May 15, 2020	BUY	$10.27 - $21.23 $50,713 - $104,833	4,938 Added 10.55%	51,754 $768,000
Q4 2019 Feb 14, 2020	BUY	$8.36 - $23.81 $61,997 - $176,574	7,416 Added 18.82%	46,816 $958,000
Q3 2019 Nov 14, 2019	SELL	$9.83 - $14.82 $46,201 - $69,654	-4,700 Reduced 10.66%	39,400 $387,000
Q2 2019 Aug 14, 2019	BUY	$12.9 - $20.8 $568,890 - $917,280	44,100 New	44,100 $595,000
Q3 2018 Nov 14, 2018	SELL	$34.41 - $44.23 $1.11 Million - $1.43 Million	-32,400 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$39.21 - $50.29 $345,910 - $443,658	-8,822 Reduced 21.4%	32,400 $1.27 Million
Q1 2018 May 15, 2018	SELL	$41.7 - $64.16 $345,192 - $531,116	-8,278 Reduced 16.72%	41,222 $2.03 Million
Q4 2017 Feb 14, 2018	BUY	$28.58 - $49.91 $799,439 - $1.4 Million	27,972 Added 129.93%	49,500 $2.24 Million
Q3 2017 Nov 14, 2017	BUY	$23.08 - $34.92 $496,866 - $751,757	21,528	21,528 $752,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $647M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.